Figure 2
Graph showing that in patients with baseline VAS > 56.4 mm, those treated with one injection experienced a greater reduction in VAS pain than those treated with combined injections at 3-month follow-up.
Figure 2 | Scientific Reports
Graph showing that in patients with baseline VAS > 56.4 mm, those treated with one injection experienced a greater reduction in VAS pain than those treated with combined injections at 3-month follow-up.
